TNFSF10 and chronic myelogenous leukemia, BCR-ABL1 positive: Additionally, lemon-derived PENPs have been employed to deliver TRAIL pathway activators, inducing apoptosis in chronic myeloid leukemia (CML) cells and highlighting their potential utility in tumor immunotherapy [30].